SCI Pharmtech, Inc. (TPE:4119)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.00
-0.30 (-0.57%)
Aug 19, 2026, 1:30 PM CST

SCI Pharmtech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,2611,3441,5241,204899.74864.22
Revenue Growth
-18.83%-11.81%26.54%33.83%4.11%-67.86%
Gross Profit
305.16351.03410.67350.32291.18208.09
Operating Income
104.02155.25198.29160.3118.9773.66
Net Income
60.12107.37534.68294.72308.7855.7
Earnings Per Share
0.500.904.462.692.870.52
EPS Growth
-87.65%-79.86%65.80%-6.27%456.63%-84.53%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Italy
218.93274.73313.71204.82244.03
Switzerland
75.39130.9671.3854.4652.74
Taiwan
114.62144.9596.23109.3258.52
Germany
99.66100116.08130.4692.76
Netherlands
60.13114.2654.01--
Japan
208.5574.38116.55110.2419.51
United States
212.36128.13127.4793.27108.24
Spain
90.32159.8433.29-30.31
Other Countries
206.04269.2203.67142.26109.32
Belgium
57.72127.329.94--
Total
1,3441,5241,204899.74864.22

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
84.0774.8692.761,031264.37692.63
Total Debt
1,083987.18990.391,042545.382.16
Net Cash (Debt)
-999.1-912.39-297.63-11.42-281.01690.48
Net Cash Growth
-----9.52%
Net Cash Per Share
-8.25-7.62-2.48-0.10-2.616.42

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
223.89220.32860.52215.77296.57280.28
Capital Expenditures
-398.32-610-946.64-1,029-1,168-771.03
Free Cash Flow
-174.44-389.68-86.12-813.59-871.02-490.75
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
24.21%26.12%26.95%29.09%32.36%24.08%
Operating Margin
8.25%11.55%13.01%13.31%13.22%8.52%
Pretax Margin
6.04%7.61%42.45%30.24%43.10%7.58%
Profit Margin
4.77%7.99%35.09%24.47%34.32%6.44%
FCF Margin
-13.84%-29.00%-5.65%-67.56%-96.81%-56.79%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.7500.7501.5001.2500.222
Dividend Per Share Growth
-50.00%-50.00%20.00%462.56%-
Dividend Yield
1.43%1.57%1.72%1.36%0.28%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
103.9254.2020.2539.2530.12143.85
Forward PE
-47.2629.3429.3439.4789.36
PS Ratio
4.934.337.119.6110.349.27